Is TB-500 Legal in Virginia? Federal Law, State Rules, and How to Get It

HealthRX.com

Federal rules don't settle TB-500 status in Virginia

Print or save as PDF

See the public record for TB-500

  • Substance / TB-500, a synthetic 7-amino-acid fragment of thymosin beta-4 [1]
  • FDA approval / None in the US or in Canada, Australia, the UK, Belgium, Ireland, France, Norway, Germany, Spain or Italy [1]
  • FDA bulks lists / Not on the pharmacy list or the outsourcing-facility list [2][3][4]
  • July 2026 advisory vote / Committee recommended adding it; advice only, not binding [7][5]
  • HHS October 2026 policy / Draft, non-binding enforcement discretion for TB-500 acetate injection [5][6]
  • Virginia law / Not determined by federal information
  • Sport / Prohibited at all times by WADA [8][9]

What TB-500 is

TB-500 is a synthetic 7-amino-acid fragment of thymosin beta-4, residues 17 to 23, N-acetylated, with a molecular weight of about 889 g/mol [1]. It is not full-length thymosin beta-4, and FDA found several salts and derivatives, including different active moieties, sold under the same name [1].

Is TB-500 on FDA's compounding lists?

No. It appears in none of the three categories on FDA's list for state-licensed pharmacies and physicians (updated May 14, 2026) or on FDA's list for outsourcing facilities (updated March 21, 2025), and the category 1 policy does not reach it [2][3][4]. FDA found no pharmacy marketing a compounded TB-500 product and no outsourcing facility reporting one [1].

It does appear in the nominated-but-withdrawn table on FDA's page about bulk substances that may carry significant safety risks. That table holds substances previously in category 2 whose nominators withdrew them, and removal from category 2 was not a safety finding [10]. FDA said it has not identified any human exposure data on drug products containing the fragment [10].

What changed in 2026

FDA staff proposed in a July 2026 briefing document that neither TB-500 free base nor TB-500 acetate be added to the pharmacy bulks list [1]. The Pharmacy Compounding Advisory Committee voted on July 23, 2026 in favor of adding it, against the staff recommendation. That advice is not binding, and listing takes formal rulemaking [7][5].

HHS filed a draft enforcement-discretion policy on October 28, 2026, Federal Register document 2026-22192, scheduled for publication October 30, 2026 with comments due two weeks later [5]. It names TB-500 among six peptides and covers TB-500 acetate given by subcutaneous or intramuscular injection. HHS says it 'does not intend to take enforcement action' against a state-licensed pharmacy, federal facility or licensed physician compounding it if the policy's conditions are met, such as a single active ingredient, a patient-specific prescription and an FDA-registered manufacturer with a certificate of analysis [5][6]. The notice says it 'does not establish any rights for any person and is not binding on HHS or the public' [5].

Does Virginia add anything?

Federal compounding materials describe FDA's and HHS's positions. They do not establish whether Virginia law permits or prohibits possessing, selling or prescribing TB-500, and this article cannot give a definitive Virginia-specific answer.

What is known about human evidence and safety

FDA found no article in which TB-500 was given to a person, and none of the three papers the nominator cited involved TB-500 in humans [1]. FDA also found no human pharmacokinetic or pharmacodynamic data by any route, so safety in humans is unknown [1]. In an in-vitro scratch-wound test, TB-500 at 50 micrograms/mL did not induce wound closure in fibroblast cultures [1]. FDA's adverse-event database search through March 26, 2025 retrieved no TB-500 reports. Its food and supplement complaint system retrieved two cases about a blended TB-500 and BPC-157 product, with no safety assessment [1]. FDA's stated concern for injectable TB-500 is immunogenicity [1].

Is TB-500 banned in sport?

Yes. WADA's Prohibited List names 'Thymosin-beta4 and its derivatives e.g. TB-500' in section S2.3, growth factors and growth factor modulators. It is prohibited at all times, in and out of competition, and it is on the 2026 List and stays on the 2027 List [8][9].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. What did FDA's review find about people given the fragment in published articles?

Question 1 of 4

Score: 0 right, 0 of 4 answered

Is TB-500 legal in Virginia?
TB-500 is not FDA-approved and is not on FDA's compounding lists, and category 1 enforcement discretion does not cover it [1][2][3][4]. Federal information does not settle whether Virginia law permits or prohibits it.
Can a Virginia pharmacy fill a TB-500 prescription?
FDA's lists provide no listed compounding pathway for TB-500 [2][3][4]. A draft HHS policy says HHS does not intend to take enforcement action for certain TB-500 acetate injections when its conditions are met, but the draft is non-binding and is not an approval [5][6]. Compounded drugs are not FDA-approved, so FDA does not review their safety, effectiveness or quality before marketing [5].
Has TB-500 been given to a person in a published study?
FDA's review found no article in which TB-500 was given to a human [1].
Is TB-500 banned for athletes?
Yes. WADA names thymosin-beta4 and its derivatives, including TB-500, in section S2.3, and it is prohibited at all times in and out of competition [8]. It is on both the 2026 and 2027 Prohibited Lists [8][9].
Show all 10 referencesHide references
Evidence overview for Is TB-500 Legal in Virginia? Federal Law, State Rules, and How to Get It